RemeGen , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow-0.42
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
RemeGen , Ltd. (REGMF) currently reports a PEG ratio of -0.42. That is below the Healthcare sector average of 27.75. Use the charts on this page to explore RemeGen , Ltd.'s PEG ratio history and peer comparisons.
RemeGen , Ltd.'s PEG ratio of -0.42 is lower than the Healthcare sector average of 27.75. That is roughly 101.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates RemeGen , Ltd.'s market price to a fundamental measure such as earnings, sales, or book value. At -0.42, REGMF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -0.42, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.75. From there, open related valuation or income-statement pages for RemeGen , Ltd., and consider following REGMF for alerts when major investors trade the stock.
RemeGen , Ltd. is classified in the Healthcare sector. On PEG ratio, it currently shows -0.42 versus a sector average near 27.75. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing REGMF with unrelated industries.
